YPI-008

N/A

Report date: 2024/12/04 15:34:30
NME

Base Information

Drug NameYPI-008
Drug Alias NameYPI-008NM-401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYungjin Pharm Co LtdNeuramedy Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYungjin Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A